9FYU image
Deposition Date 2024-07-04
Release Date 2025-05-14
Last Version Date 2025-07-16
Entry Detail
PDB ID:
9FYU
Title:
Crystal structure of the engineered photoenzyme VEnT1.0
Biological Source:
Source Organism:
Loligo vulgaris (Taxon ID: 6622)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.52 Å
R-Value Free:
0.17
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Diisopropyl-fluorophosphatase
Chain IDs:A, B
Chain Length:326
Number of Molecules:2
Biological Source:Loligo vulgaris
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
A1IHG A PHE modified residue
Ligand Molecules
Primary Citation

Abstact

The development of [2 + 2] cyclases containing benzophenone triplet sensitizers highlights the potential of engineered enzymes as a platform for stereocontrolled energy transfer photocatalysis. However, the suboptimal photophysical features of benzophenone necessitates the use of ultraviolet light, limits photochemical efficiency and restricts the range of chemistries accessible. Here we engineer an orthogonal Methanococcus jannaschii tyrosyl-tRNA synthetase/tRNA pair for encoding thioxanthone triplet sensitizers into proteins, which can efficiently harness visible light to drive photochemical conversions. Initially, we developed an enantioselective [2 + 2] cyclase that is orders of magnitude more efficient than our previously developed photoenzymes (kcat = 13 s-1, >1,300 turnovers). To demonstrate that thioxanthone-containing enzymes can enable more challenging photochemical conversions, we developed a second oxygen-tolerant enzyme that can steer selective C-H insertions of excited quinolone substrates to afford spirocyclic β-lactams with high selectivity (99% e.e., 22:1 d.r.). This photoenzyme also suppresses a competing substrate decomposition pathway observed with small-molecule sensitizers, underscoring the ability of engineered enzymes to control the fate of excited-state intermediates.

Legend

Protein

Chemical

Disease

Primary Citation of related structures